O-053 The potential of circulating mirnas as predictive biomarkers for endovascular treatment outcomes in intracranial aneurysms

Santhosh Arul(Mayo Clinic), Ramanathan Kadirvel(Mayo Clinic in Florida), Atakan Orscelik(University of California, San Francisco), Yeşim Şenol(Mayo Clinic in Arizona), Waleed Brinjikji(WinnMed), O Mereuta(Mayo Clinic in Arizona), Rajiv Kumar(Karnataka Veterinary Animal and Fisheries Sciences University), D Kallmes(Mayo Clinic in Arizona), Jennifer Ayers-Ringler(Mayo Clinic)
Unknown
July 1, 2023
10.1136/jnis-2023-snis.53
Cited by 0

Related Papers

International Retrospective Study of the Pipeline Embolization Device: A Multicenter Aneurysm Treatment Study
|American Journal of Neuroradiology|2014|568
Long-Term Clinical and Angiographic Outcomes Following Pipeline Embolization Device Treatment of Complex Internal Carotid Artery Aneurysms: Five-Year Results of the Pipeline for Uncoilable or Failed Aneurysms Trial
|Neurosurgery|2016|440
Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
|Journal of Clinical Oncology|2008|377
Non-Stem Cell Origin for Oligodendroglioma
|Cancer Cell|2010|239
Asymmetry-Defective Oligodendrocyte Progenitors Are Glioma Precursors
|Cancer Cell|2011|227